Wall Street is positive on Kala Pharmaceuticals Inc (KALA). On average, analysts give KALA a Strong Buy rating. The average price target is $19.857, which means analysts expect the stock to increase by 418.46% over the next twelve months. That average ranking earns KALA an Analyst Rating of 65, which is better than 65% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating KALA a Strong Buy today. Find out what this means to you and get the rest of the rankings on KALA!